|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 25, 2016 ) Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016
Summary
Global Markets Directs, Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Plaque Psoriasis (Psoriasis Vulgaris), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Plaque Psoriasis (Psoriasis Vulgaris) and features dormant and discontinued projects.
Browse Market info, get a Sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=719499
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Click to submit Query/ Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=719499
Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Plaque Psoriasis (Psoriasis Vulgaris) Overview 11
Therapeutics Development 12
Pipeline Products for Plaque Psoriasis (Psoriasis Vulgaris) Overview 12
Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics under Development by Companies 13
Plaque Psoriasis (Psoriasis Vulgaris) Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Unknown Stage Products 21
Plaque Psoriasis (Psoriasis Vulgaris) Products under Development by Companies 22
Plaque Psoriasis (Psoriasis Vulgaris) Companies Involved in Therapeutics Development 28
3SBio Inc. 28
AbGenomics International, Inc. 29
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Latest Press-Releases: http://www.researchmoz.us/pressrelease
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
